Muche, Achenef Asmamaw
Olayemi, Oladapo O.
Gete, Yigzaw Kebede
Funding for this research was provided by:
Pan African University (PAU), a continental initiative of the African Union Commission (AU), Addis Ababa, Ethiopia
Article History
Received: 27 March 2019
Accepted: 5 September 2019
First Online: 13 September 2019
Ethics approval and consent to participate
: The study was conducted after ethical approval was obtained from the Institutional Review Board (IRB) of the University of Ibadan/University College Hospital (Ref.No; UI/EC/17/0435) and the IRB of the University of Gondar (Ref.No; O/V/P/RCS/05/811/2018). Permission from the Amhara Public Health Institute and the health authorities of the study sites was also received prior to the start of the study. Before enrolment, participants were informed about the study, its aims, effects, and importance of screening. Written consent was obtained by trained data collectors. Then, participants were subjected to full history taking through clinical examinations and laboratory investigations. All information was made anonymous in order to maintain confidentiality. Participants diagnosed with GDM was referred to health providers and get possible treatment options in their respective public health facilities.
: Not applicable.
: The authors declare that they have no competing interests.